Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 574
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT02629809 Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in… |
Cyclophosphamide | SEP | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Hebei Senlang Biotechnology Inc.,… | United States · M D Anderson Cancer Center, Houston, … | 2016-03-18 → 2028-03-31 | Ouvrir |
| NCT01361711 Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymp… |
Alemtuzumab | SEP | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Northwestern University | United States, Sweden · Karolinska University Hospita… | 2011-06 → 2027-05 | Ouvrir |
| NCT07859592 Labyrinthin Vaccination in Veterans With Lung Adenocarcinoma |
LabVax 3(22)-23 and GM-CSF (adjuv… | Myopathies | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | VA Office of Research and Develop… | United States · Kansas City VA Medical Center, Kansas… | 2026-12-01 → 2035-12-01 | Ouvrir |
| NCT06772116 JR — Focal Therapy in Localized Prostate Cancer: a Prospective Registry |
Focal Therapy | Cancer | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Institut Mutualiste Montsouris | Non communiqué | 2025-02 → 2032-02 | Ouvrir |
| NCT05270642 Plan for Microwave Thermal Field |
Microwave Thermal guided by Plan … | Cancer | Non applicable | UNKNOWN | En attente / non publié | Chinese PLA General Hospital | China · Chinese PLA General Hospital, Beijing, China | 2021-10-01 → 2022-12-30 | Ouvrir |
| NCT07242820 COSA-RCT — Reducing Neoplasia Recurrence After Non-thermal Endoscopic R… |
Adjuvant thermal ablation | Cancer | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Centre hospitalier de l'Universit… | Canada · Centre Hospitalier de l'Universite de Montre… | 2026-12 → 2032-05 | Ouvrir |
| NCT07748481 Comparison of the Therapeutic Efficacy of Non-touch Microwave Ablation,… |
No-touch Microwave Ablation | Cancer | À vérifier | NOT_YET_RECRUITING | En attente / non publié | The First Hospital of Jilin Unive… | Non communiqué | 2026-10-01 → 2029-05-01 | Ouvrir |
| NCT02729727 Clinical Study to Evaluate CryoBalloon™ Ablation System in Patients Und… |
CryoBalloon Ablation System | Cancer | Non applicable | COMPLETED | En attente / non publié | Pentax Medical | Netherlands · Academic Medical Centre Amsterdam, Amst… | 2016-03 → 2016-06-30 | Ouvrir |
| NCT06472661 Mel 70 — FUSA With Intratumoral PolyICLC in Regionally Advanced Resecta… |
Echopulse or Echopulse HD | Cancer | Phase 1 | RECRUITING | En attente / non publié | University of Virginia | United States · University of Virginia, Charlottesvil… | 2024-09-27 → 2026-08 | Ouvrir |
| NCT04298242 Magnetic Resonance Guided High Intensity Focused Ultrasound in Advanced… |
ExAblate 2100 | Cancer | Non applicable | COMPLETED | En attente / non publié | Stanford University | United States · Stanford Cancer Center, Stanford, Uni… | 2020-11-22 → 2021-06-15 | Ouvrir |
| NCT04494568 ENDO-HIFU-R1 — Evaluation of High Intensity Focused Ultrasound (HIFU) i… |
HIFU treatment | Cancer | Non applicable | COMPLETED | En attente / non publié | EDAP TMS S.A. | France · CHU de Angers, Angers, France | Clinique de … | 2020-08-27 → 2022-11-30 | Ouvrir |
| NCT01965002 Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx… |
MRgHIFU | Cancer | Non applicable | TERMINATED | En attente / non publié | Pejman Ghanouni | United States · Stanford University School of Medicin… | 2014-05 → 2015-03-24 | Ouvrir |
| NCT07100080 Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexe… |
Iza-bren | Cancer | Phase 2/3 | RECRUITING | En attente / non publié | Bristol-Myers Squibb | United States, Argentina, Belgium, Canada, Chile, Chi… | 2025-11-05 → 2030-11-15 | Ouvrir |
| NCT07278336 A Study to Assess Adverse Events, Change in Disease Activity and How In… |
ABBV-901 | Cancer | Phase 1 | RECRUITING | En attente / non publié | AbbVie | United States, Australia, France, Israel, Japan, Port… | 2025-11-27 → 2029-01 | Ouvrir |
| NCT07659795 TARGET-D 203 — A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mu… |
VS-7375 | Cancer | Phase 2 | RECRUITING | En attente / non publié | Verastem, Inc. | United States, Australia · BRCR - Tamarac, Tamarac, U… | 2026-07-28 → 2028-12 | Ouvrir |
| NCT07476287 Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF0… |
PF-08634404 | Cancer | Phase 2 | RECRUITING | En attente / non publié | Pfizer | United States, Australia, Brazil, China, France, Hong… | 2026-07-02 → 2031-03-24 | Ouvrir |
| NCT07868172 GST101-001 — GST101 in Participants With RAS-Mutant Advanced Solid Tumo… |
GST101 | Cancer | Phase 1/2 | NOT_YET_RECRUITING | En attente / non publié | Genuine Seed Therapeutics (Zhuhai… | China · Fudan University Shanghai Cancer Center, Shan… | 2026-10 → 2028-10 | Ouvrir |
| NCT03141684 Testing Atezolizumab Alone or Atezolizumab Plus Bevacizumab in People W… |
Atezolizumab | Cancer | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · Beth Israel Deaconess Medical Center,… | 2017-04-25 → 2026-10-31 | Ouvrir |
| NCT06757634 Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With … |
Arm A: Gedatolisib + Palbociclib … | Cancer | Phase 3 | RECRUITING | En attente / non publié | Celcuity Inc | United States, Argentina, Australia, Belgium, Bulgari… | 2025-07-24 → 2033-07-30 | Ouvrir |
| NCT07859722 CT- Versus MRI-Based Planning for High-Dose-Rate Prostate Brachytherapy… |
Magnetic Resonance Imaging | Cancer | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Emory University | United States · Emory Proton Therapy Center, Atlanta,… | 2026-11-02 → 2029-05-31 | Ouvrir |
| NCT05386108 ELECTRA — Study of Abemaciclib and Elacestrant in Participants With Bra… |
Elacestrant | Cancer | Phase 1/2 | RECRUITING | En attente / non publié | Stemline Therapeutics, Inc. | United States, Belgium, France, Germany, Greece, Ital… | 2022-08-31 → 2026-12 | Ouvrir |
| NCT07572136 Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Pa… |
TSLPR-CART | Cancer | Phase 1 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2026-10-14 → 2032-06-30 | Ouvrir |
| NCT06904066 Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs f… |
aldesleukin | Cancer | Phase 1 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2026-10-14 → 2029-04-30 | Ouvrir |
| NCT04269902 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic… |
Biospecimen Collection | Cancer | Phase 3 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States, Canada · Abbott-Northwestern Hospital,… | 2021-03-02 → 2028-10-01 | Ouvrir |
| NCT03934372 Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent o… |
Ponatinib | Cancer | Phase 1/2 | RECRUITING | En attente / non publié | Incyte Biosciences International … | Belgium, France, Italy, Netherlands, Spain, Sweden, U… | 2020-01-29 → 2028-02-01 | Ouvrir |